Clinical Trial Update: Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF [NA]

View source ↗

Summary

A clinical trial investigating the Lambre Device for occluding the left atrial appendage in non-valvular atrial fibrillation patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Left Atrial Appendage Thrombosis
• Stroke

Drugs mentioned

• Lambre Device

Snippet

Sponsor: Brian O'Neill MD | Conditions: Atrial Fibrillation, Left Atrial Appendage Thrombosis | NA | Status: WITHDRAWN